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HISTORICAL VIGNETTES IN VASCULAR SURGERY
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266The ﬁrst Gore-Tex femoral-popliteal bypass
Roger T. Gregory, MD,a and James S. T. Yao, MD, PhD,b Norfolk, Va; and Chicago, IllIn scientiﬁc investigation, “Who’s on First” is often an
ongoing debate when it comes to medical discoveries and
scientiﬁc priority.1 Surgeons embrace the idea of being ﬁrst
to perform an operation, particularly if history later shines
upon it a favorable light.
Is it important to be ﬁrst? The Olympic games initiated
by ancient Greeks made heroes out of those who came in
ﬁrst in an event. In a presentation to the 25th Anniversary
Veith Symposium on “Firsts” in Vascular Surgery: Who Did
What “First,” Rich gave the subject an in-depth examina-
tion. He found that history is replete with claims of ﬁrst.
Many of these claims were associated with controversy.2
Firsts in vascular surgery are numerous. It is generally
acknowledged that William Harvey was the ﬁrst to discover
circulation. The Chinese, however, claimed they discovered
the concept of blood circulation some 2000 years before
Harvey.3 Similarly, coronary arteriosclerosis is often
regarded as a Western disease, yet a recent report has found
coronary arteriosclerotic disease existed in China >2200
years ago.4
Besides “ﬁrst operations,” there are also “famous oper-
ations.” Harold Ellis, in his book Famous Operations,
divided the “famous operation” into three types: type I is
the breakthrough operation. A type II operation may be
insigniﬁcant itself, but it marks the introduction of some
important point in surgical technique. Finally, the type
III operation depends entirely on the patient; the operation
itself may be routine, but the patient is a famous person,
thus an operation, an act between the surgeon and the
patient, does carry extra meaning and signiﬁcance.5
Among all ﬁrst operations, none can surpass the “blue
baby” operation by Blalock and Taussig, performed at the
Johns Hopkins Hospital on November 29, 1944.6 To
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the homograft replacement of an abdominal aortic aneu-
rysm. Dubost of France did the operation on March 29,
1951. It was later known that Schafer and Dardin, of Kan-
sas, did the same operation on March 2, 1951, 27 days
before Dubost. However, their patient died 29 days after
the operation, 1 day short of the magic 30 days to be
counted as a “survival.”8 Schafer and Dardin thus became
just a footnote in the history of aneurysm surgery.
A ﬁrst operation also depends on the date of the report
in the medical literature. The clearest example involves the
most common open arterial operation, carotid endarterec-
tomy, with multiple surgeons claiming to have been ﬁrst to
perform the procedure. Eastcott, Pickering, and Rob re-
ported the ﬁrst carotid surgery on May 19, 1954, and
the report usually has been cited as the ﬁrst operation.
However, in a 19-year follow-up report by DeBakey in
1975, it appears that DeBakey did the procedure on
August 7, 1953, some 9 months before Eastcott et al. In
the quest for being the ﬁrst in carotid endarterectomy,
Dr Denton Cooley introduced his publication on the
history of carotid endarterectomy with the quote by Ralph
Waldo Emerson9: “Every child of the Saxon race is
educated to wish to be ﬁrst. It is our system.”
Thus, the ﬁrst Gore-Tex (W. L. Gore and Associates,
Flagstaff, Ariz) femoral popliteal bypass reported here is
both the product of a natural desire and an interesting
and important landmark in surgical history.CASE REPORT
An elderly diabetic woman presented to our ofﬁce in Norfolk,
Virginia, with critical lower extremity ischemia <1 year after I
entered clinical practice in 1974. She had the additional challenge
of having had a ligation and stripping of bilateral lower extremity
saphenous varicosities many years before. Angiography revealed
an occluded superﬁcial femoral artery, a patent popliteal artery
segment below the knee, and limited runoff. The profunda was
patent but small.
My partner, Dr Jock Wheeler (later Dean of Eastern Virginia
Medical School), and I had encountered this type of situation on
several occasions, and it was always a dilemma. We had used an
expanded polytetraﬂuoroethylene (PTFE) IMPRA graft (Impra
Inc, Tempe, Ariz) for a femoral-tibial bypass several months
earlier. The graft thrombosed in the early postoperative phase,
and an attempt at thrombectomy with a Fogarty catheter resulted
Fig. Illustration shows a Gore-Tex graft being placed.
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this experience, we were not inclined to try another PTFE graft.
And yet, our dilemma remained.
We had heard that another new prosthetic graft made of
PTFE had been produced by the W. L. Gore Company. The
company was quickly contacted. They were aware of the problems
with burst/hoop strength of the PTFE graft because a few of their
sample grafts had developed graft aneurysms (personal communi-
cation, W. L. Gore Company, August 1975), later formally re-
ported by Campbell et al.10 This had prompted them to recall all
of their sample grafts. By July 31, 1975, the W. L. Gore Company
had re-engineered the graft by reinforcement with a thin outer
sheath, which resolved the issue of hoop strength. This activity pre-
dated the requirement for U.S. Food and Drug Administration
approval of new devices; these changes were all in-house
modiﬁcations.
“When do you need it?” they replied when I asked to see the
graft.
“As soon as possible,” I said.
Within a few days, Jack Hoover, a new associate with W. L.
Gore, was in our ofﬁce with unsterilized samples of the graft,
which looked reasonable and handled well. We ordered six
6-mm reinforced grafts and two 7-mm to 4-mm grafts on August
25, 1975,11 which arrived 2 days later. On August 28, 1975, we
performed a below-knee femoral-popliteal bypass with a 6-mm
reinforced Gore-Tex graft, which was sterilized on site. The anas-
tomoses were performed with 5-0 Prolene (Ethicon, Somerville,
NJ) suture on an RB-1 taper needle. When the occlusive clamps
were released, the anastomoses leaked through the needle holes
like the sprinkler head on a watering pot. We had seen this with
the IMPRA graft and were not overly alarmed. We quickly
reversed the heparin given before anastomotic construction, sprin-
kled thrombin powder over the bleeding anastomoses, and applied
careful pressure. Over the next 5 to 10 minutes, hemostasis was
regained.
The patient did well postoperatively, and limb salvage was
achieved with a patent graft for several years. Hoover informed
us later that this was the ﬁrst use of the reinforced Gore-Tex graft:
Ours had been their ﬁrst order.11
BYPASS: A REVOLUTIONARY CONCEPT
In 1976, Campbell et al12 reported a small series of
patients with femoral-popliteal Gore-Tex bypass grafts.12
This prompted us to organize our experience. By 1977,
we had a series of some 30 patients with reasonable
short-term results. These results were submitted for publi-
cation, but rejected. Subsequently, the series was presented
at the Virginia Surgical Society meeting (because we were
the only full-time vascular surgeons in the state, there
was no state vascular society at that time). After the presen-
tation, there was only one question: “Are anticoagulants
needed postoperatively?” Otherwise, there were no
comments or discussion.
The bypass principle, described by Jeger in 1913, was
one of the most revolutionary concepts in the history of
vascular surgery.13 Interestingly, Jeger never performed
a bypass. This concept allowed vascular surgeons to aggres-
sively attack segmental arterial occlusive disease. Thediscovery of a fabric graft material by Voorhees, in 1951,
allowed the bypass principle to ﬂourish.14 The DeBakey-
led Baylor group used the Dacron graft (DuPont, Wil-
mington, Del) to replace aneurysms or to bypass occlusive
disease in the aortoiliac position, which helped the growth
of the era of reconstructive arterial surgery. However, the
use of prosthetic grafts in limb salvage for critical ischemia
secondary to severe infrainguinal arterial occlusive disease
remained a serious issue because the results were not ideal.
The development of femoral bypass dates back to the
early 20th century, yet it was Kunlin, in 1948, who caught
the attention of vascular surgeons internationally when he
reported a femoral-popliteal bypass using a saphenous
vein graft.13 The extension of the femoral bypass to the
Table. Chronology of development of infrainguinal bypass since Kunlina
Date Surgeon Development
1951 E. Lowenberg Saphenous vein, lateral approach
1958 J. J. McCaughan Distal popliteal artery exposure
1959 G.C. Morris Posterior approachdposterior tibial artery
1959 C. Rob In situ vein graft
1960 E. C. Palma Vein graft to posterior tibial artery
1961 J. J. McCaughan Vein graft to posterior and anterior tibial artery, calf level
1966 J. J. McCaughan Femoral to posterior tibial (ankle) vein graft
1966 H. E. Garrett Bypass to distal posterior tibial artery
1967 J. A. Mannick Bypass to isolated popliteal artery
1967 J. J. Ochsner Dorsalis pedis
1968 H. E. Garrett Tibial arteries at ankle level
1969 V. V. Kakkar Cephalic vein
1971 D. A. DeLaurentis Sequential graft
1972 W. A. Dale Composite graft
1975 F. A. Reichle, R. Tyson Peroneal artery
1988 E. Ascer, F. J. Veith, S.K. Gupta Bypass to plantar artery
aModiﬁed from Yao JS, Pearce WH. Preface. In: Yao JS, Pearce WH, eds. The ischemic extremity: advances in treatment. East Norwalk, CT: Appleton &
Lange; 1995.
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slow to follow (Table). Improvement in technique was
also very slow, although Cartier reported use of an in situ
vein graft in 1960.15 This technique failed to gain popu-
larity until Leather et al16 reported their experience in
1979, including some technical reﬁnements. Despite this
progress, autogenous tissue was still viewed as the ideal
bypass graft. The need for an off-the-shelf prosthetic graft
for femoral-popliteal bypass to be used when autogenous
tissue was not available or in certain high-risk patients
was widely acknowledged.
The expanded PTFE Gore-Tex tubular graft was ﬁrst
used as a venous prosthesis by Dr Ben Eiseman.17 This is
a fascinating story of serendipity, imagination, and friend-
ship18 that Chandler called a magical moment in vascular
surgery.19 The accidental discovery of the Gore-Tex graft
is of interest because it led to renewed hope that a suitable
vascular prosthetic graft for femoral arterial bypass had
been found. Several investigators began to report the
successful use of the PTFE graft in the arterial circulation.20
However, it was the multicenter randomized trial by Veith
et al21 that ﬁrmly established the value of the PTFE graft in
infrainguinal arterial reconstruction.
Other substitutes for the saphenous vein graft have been
tried, including the human umbilical cord vein, mandril
grafts, bovine grafts, cryopreserved grafts, and composite
grafts. These grafts garnered scattered use, but none
received the attention and wide application that the Gore-
Tex graft did. Although the ﬁrst use of a Gore-Tex graft
for a femoral-popliteal bypass in 1975 received little initial
attention, this graft went on to international application in
>5 million cases and underwent several improvements
(thin walled, stretch, and ringed; personal communication,
W. L. Gore Company, April 2012). The Gore-Tex graft is
not yet the ideal replacement for an autogenous saphenous
vein, but it has been a substantial step forward.
On April 3, 1991, we implanted the ﬁrst Gore-Tex
Stretch graft in the aortobiiliac position (Fig), this time atthe invitation of Don Lass, another W. L. Gore associate.
The suture material for the anastomoses was 3-0 Gore-
Tex, which offered a considerable improvement over the
sutures used for the ﬁrst femoral-popliteal bypass. Leaking
after clamp release was minimal. This event, however, was
not followed by the same explosive popularity as the Gore-
Tex femoral-popliteal bypass graft placed 16 years earlier.
We are fully aware that being ﬁrst does not always mean
being best. These ﬁrst two cases are reported as a footnote
to a graft that was discovered accidentally, followed by
worldwide acceptance and widespread application.REFERENCES
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